Chemical
Ziprasidone & intermediates
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
CAS: 146939-27-7
Formula: C21H21ClN4OS
Specifications
Key details (from tblproducts)
| CAS | 146939-27-7 |
| Molecular formula | C21H21ClN4OS |
| Molecular weight | 412.9 g/mol |
| IUPAC | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| Chemtos | United States | In Stock | View |
| Chemtos | United States | In Stock | View |
| Chemtos | United States | In Stock | View |
| Alsachim | FRANCE | In Stock | View |
| Artis Biotech India LLP | India | In Stock | View |
| AvaChem Scientific | United States | In Stock | View |
| CRS Laboratories | UNITED KINGDOM | In Stock | View |
| HPC Standards | Germany | — | View |
| LKT Labs | United States | In Stock | View |
| Opulent Pharma | INDIA | In Stock | View |
| Parchem | United States | In Stock | View |
| Qmx Laboratories Limited | England | In Stock | View |
| R & S Chemicals | India | In Stock | View |
| Shanghai Daishang Chemicals | CHINA | In Stock | View |
| Shodhana Laboratories Limited | INDIA | In Stock | View |
| Synthese AptoChem Inc | Canada | In Stock | View |
| Targetmol | United States | — | View |
| AptoChem | Canada | In Stock | View |
| AptoChem | Canada | In Stock | View |
| AUROBINDO PHARMA LTD | India | — | View |
| Changzhou Sinly Pharmchem Co., Ltd. | China | In Stock | View |
| GENSYNTH FINE CHEMICALS | India | — | View |
| JUBILANT LIFE SCIENCES | India | — | View |
| KRR DRUGS & INTERMEDIATES PVT. LTD. | India | — | View |
| KSHATRIYA LABORATORIES PVT. LTD | India | — | View |
| MAITHILI LIFE SCIENCES PVT LTD | India | — | View |
| Shodhana Laboratories Ltd. | India | — | View |
| SST Corporation | United States | — | View |
| SYNERGENE ACTIVE INGREDIENTS | India | — | View |
| XENOS Bioresources, Inc. | United States | — | View |